GlassScriptPhysician profile
Elizabeth A Case
NPI 1376579359
$1,051.08
in general payments reported to CMS, 2019-2025
27 companies · $489 in 2025
The $489 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $69.76 · 2021: $34.50 · 2022: $122 · 2023: $37.52 · 2024: $112 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $214.89 | 2019-2025 | |
| Applied Medical Resources Corporation | $87.54 | 2025 | Gelpoint V-Path |
| Exeltis, USA INC. | $86.33 | 2022-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $60.64 | 2025 | |
| Organon LLC | $58.21 | 2024-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $49.34 | 2025 | Myfembree |
| Agile Therapeutics, INC. | $43.04 | 2022-2023 | Twirla |
| Sage Therapeutics, LLC | $40.94 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $40.38 | 2019-2020 | |
| Lilly USA, LLC | $33.20 | 2025 | Zepbound |
| Exact Sciences Corporation | $30.70 | 2024-2025 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $29.87 | 2019-2020 | |
| Hologic Sales and Service, LLC | $27.73 | 2020-2022 | |
| Glaxosmithkline, LLC. | $25.38 | 2024 | Nucala |
| Mayne Pharma Commercial LLC | $23.75 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $20.32 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.68 | 2025 | Caplyta |
| Avion Pharmaceuticals | $19.63 | 2021 | |
| Supernus Pharmaceuticals, INC. | $18.91 | 2025 | Qelbree |
| Ethicon US, LLC | $17.57 | 2019 | |
| Astellas Pharma US INC | $17.34 | 2025 | Veozah |
| Baxter Healthcare | $16.93 | 2025 | Tisseel |
| Arjo INC. | $15.93 | 2025 | |
| Davol INC. | $14.94 | 2025 | Arista |
| Pfizer INC. | $13.78 | 2024 | |
| Therapeuticsmd, INC. | $12.78 | 2020 | |
| Lupin INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.